|
EDF1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.98543437035914E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.72220000038692E-07 |
| Normal-vs-Stage2 |
2.282300E-02 |
| Normal-vs-Stage3 |
1.07039999974745E-07 |
| Normal-vs-Stage4 |
1.555870E-04 |
| Stage1-vs-Stage2 |
3.525200E-01 |
| Stage1-vs-Stage3 |
7.464400E-01 |
| Stage1-vs-Stage4 |
5.101400E-01 |
| Stage2-vs-Stage3 |
2.332800E-01 |
| Stage2-vs-Stage4 |
2.165200E-01 |
| Stage3-vs-Stage4 |
6.711600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.05940001215998E-09 |
| Normal-vs-AfricanAmerican |
2.02029999999409E-05 |
| Normal-vs-Asian |
3.10550000004461E-06 |
| Caucasian-vs-AfricanAmerican |
1.902140E-02 |
| Caucasian-vs-Asian |
4.705000E-01 |
| AfricanAmerican-vs-Asian |
5.202400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.00690000068593E-08 |
| Normal-vs-Female |
2.81820011771572E-10 |
| Male-vs-Female |
3.456400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.495490E-03 |
| Normal-vs-Age(41-60Yrs) |
4.33820002143648E-09 |
| Normal-vs-Age(61-80Yrs) |
1.36380000004266E-06 |
| Normal-vs-Age(81-100Yrs) |
5.917700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.978200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.105800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.151600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.871000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.075200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.174600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.697800E-02 |
| Normal-vs-Grade 2 |
5.71269999971591E-07 |
| Normal-vs-Grade 3 |
3.92290000483797E-09 |
| Normal-vs-Grade 4 |
5.034500E-04 |
| Grade 1-vs-Grade 2 |
8.502200E-01 |
| Grade 1-vs-Grade 3 |
9.714200E-01 |
| Grade 1-vs-Grade 4 |
6.646600E-01 |
| Grade 2-vs-Grade 3 |
6.648000E-01 |
| Grade 2-vs-Grade 4 |
7.205600E-01 |
| Grade 3-vs-Grade 4 |
4.926000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.27650120976364E-11 |
| Normal-vs-ccB subtype |
3.570100E-02 |
| ccA subtype-vs-ccB subtype |
1.438600E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.67739999999262E-05 |
| Normal-vs-N1 |
8.087700E-02 |
| N0-vs-N1 |
5.183400E-01 |
|
|
